[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.19.31. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1961

Chemotherapy for Cancer by Regional Perfusion

Author Affiliations

HOUSTON, TEXAS
Assistant Surgeon, M. D. Anderson Hospital and Tumor Institute, and Assistant Professor of Surgery, University of Texas Postgraduate School of Medicine (Dr. Stehlin), and Director and Surgeon-in-Chief, M. D. Anderson Hospital and Tumor Institute, University of Texas, and Professor of Surgery, University of Texas Postgraduate School of Medicine (Dr. Clark).

Arch Surg. 1961;83(2):196-202. doi:10.1001/archsurg.1961.01300140038006
Abstract

Since the work of Klopp,5,6 Creech,1-4 and others,7-10 perfusion has attracted wide attention as a method of treating patients with certain types of malignant neoplasms. In The University of Texas M. D. Anderson Hospital and Tumor Institute, 167 perfusions were performed for 131 patients during the 2½ years between Dec. 1, 1957, and June 1, 1960. The procedure has been employed as a means of studying cancer in the human subject, and for testing the effects of chemotherapeutic agents upon tumors, as well as for the treatment of patients. Even as a therapeutic measure, however, it is still regarded as largely experimental, in that sufficient time has not elapsed to permit a proper estimate of its value.

Indications 

Experimental.  —Regional perfusion, especially of the distal extremities, affords an excellent opportunity for studying the responses of tumors to chemotherapeutic agents without endangering the lives of patients, and thus

First Page Preview View Large
First page PDF preview
First page PDF preview
×